| Low Volume | High Volume | p-value |
---|---|---|---|
Number [%] | 287 [88] | 39 [12] | Â |
Age (mean years [SD]) | 56.4 [13.2] | 51.4 [16.7] | 0.65 |
Male (%) | 39 | 57 | 0.39 |
ASA (median [range]) | 3 [0–4] | 3 [0–4] | 0.38 |
ECOG (median [range]) | 1 [0–3] | 1 [0–2] | 0.63 |
Tumour markers | Â | Â | Â |
CEA (mean [SD]) | 31 [93] | 79 [131] | 0.22 |
CA19.9 (mean [SD]) | 28 [159] | 35 [51] | < 0.01 |
CA125 (mean [SD]) | 42 [109] | 177 [637] | 0.01 |
Operative outcome | Â | Â | Â |
PCI (median [range]) | 8 [1–16] | 20 [17–39] | < 0.01 |
CC-0 score (%) | 95.5 | 71.8 | < 0.01 |
HIPEC (%) | 87.5 | 89.7 | 0.11 |
Operating time (mean hours [SD]) | 6.6 [2.5] | 8.7 [3.5] | < 0.01 |
ICU LOS (mean days [SD]) | 2.3 [1.9] | 8.4 [18.6] | < 0.01 |
Hospital LOS (mean days [SD]) | 21.3 [26.4] | 31.5 [31.6] | 0.02 |
Morbidity~ (%) | 28.6 | 35.9 | < 0.01 |
Perioperative mortality (n[%]) | 2 [0.7] | 1 [2.5] | 0.96 |